Inogen (INGN) Cash & Equivalents (2012 - 2026)
Inogen (INGN) posted quarterly Cash & Equivalents of $93.1 million for Q1 2026, down 21.68% year-over-year from $118.9 million in Q1 2025, and down 10.24% quarter-over-quarter from $103.7 million in Q4 2025.
Inogen (INGN) Cash & Equivalents (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Cash & Equivalents for 15 consecutive years, with $93.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 21.68% year-over-year to $93.1 million; the TTM figure through Mar 2026 stood at $93.1 million (down 21.68% YoY), while the FY2025 annual figure was $103.7 million, down 11.66% from the prior year.
- Cash & Equivalents declined to $93.1 million in Q1 2026 per INGN's latest filing, from $103.7 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $213.4 million in Q1 2022 and bottomed at $23.7 million in Q3 2023.
- Historically, Cash & Equivalents has averaged $105.9 million across 5 years, with a median of $105.7 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 88.82% — and 2024, when it soared 350.23%.
- Inogen's Cash & Equivalents stood at $187.0 million in 2022, then plunged by 32.9% to $125.5 million in 2023, then declined by 6.44% to $117.4 million in 2024, then retreated by 11.66% to $103.7 million in 2025, then decreased by 10.24% to $93.1 million in 2026.
- Business Quant data shows INGN's Cash & Equivalents at $93.1 million in Q1 2026, $103.7 million in Q4 2025, and $106.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Inogen | 151.86 Mn | 46.32 Mn | 43.27 Mn | 87.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.28 Mn |
| Mar 31, 2026 | 93.11 Mn |
| Dec 31, 2025 | 103.73 Mn |
| Sep 30, 2025 | 106.48 Mn |
| Jun 30, 2025 | 103.69 Mn |
| Mar 31, 2025 | 118.89 Mn |
| Dec 31, 2024 | 117.42 Mn |
| Sep 30, 2024 | 105.69 Mn |
| Jun 30, 2024 | 97.92 Mn |
| Mar 31, 2024 | 107.44 Mn |
| Dec 31, 2023 | 125.49 Mn |
| Sep 30, 2023 | 23.74 Mn |
| Jun 30, 2023 | 27.69 Mn |
| Mar 31, 2023 | 23.86 Mn |
| Dec 31, 2022 | 187.01 Mn |
| Sep 30, 2022 | 209.63 Mn |
| Jun 30, 2022 | 34.76 Mn |
| Mar 31, 2022 | 213.40 Mn |
| Dec 31, 2021 | 235.52 Mn |
| Sep 30, 2021 | 241.58 Mn |